EC Number   |
Application |
Reference |
|---|
    5.1.1.7 | analysis |
a high-performance liquid chromatography method for the simultaneous assay of diaminopimelate epimerase and decarboxylase |
2147 |
| 5.1.1.7 | analysis |
simple and sensitive spectrophotometric method for the determination of meso-alpha,epsilon-diaminopimelate with meso-2,6-diaminopimelate D-dehydrogenase and its application to the assay of diaminopimelate epimerase |
2143 |
| 5.1.1.7 | drug development |
bacterial racemase, including glutamate racemase and DAP epimerase, are potential targets for the development of new agents effective against organisms resistant to conventional antibiotics |
676873 |
| 5.1.1.7 | drug development |
DAP epimerase is an attractive target for rational antibiotic design |
701554 |
| 5.1.1.7 | drug development |
DapF is considered as an attractive target for the development of antibacterial drugs |
-, 749346 |
| 5.1.1.7 | drug development |
diaminopimelate epimerase catalyzes the stereoinversion of LL-diaminopimelate to meso-diaminopimelate, a precursor of L-lysine and an essential component of the bacterial peptidoglycan. This function is vital to bacteria and the enzyme therefore represents an attractive target for the design of novel anti-bacterials |
671810 |
| 5.1.1.7 | drug development |
enzyme represents a promising target for rational drug design aimed to develop new selective antibacterial therapeutic agents |
704812 |
| 5.1.1.7 | drug development |
the enzme is an attractive target to facilitate development of antibacterial agents |
-, 728008 |
| 5.1.1.7 | drug development |
the enzyme is a promising antimicrobial target |
727975 |
| 5.1.1.7 | drug development |
the recombinant DapF produced is correctly folded and is a suitable tool for a drug development study |
-, 673738 |
